References
- Johnton JB. Chronic lymphocytic leukemia. In: Richard L, Foerster J, Lukens J, Paraskevas F, Greer JP, Lukens J, Rodgers GM, eds. Wintrobe's Clinical Hematology, 10th edn. Egypt: Mass Pub, 1999:2413.
- Couderc B, Dujols JP, Mokhtari F, Norkowski JL, Slawinski JC, Schlaifer D. The management of adult aggres-sive non-Hodgkin's lymphomas. Crit Rev Oncol Hematol 2000; 35 (1): 33–48.
- Aydogdu I, Ozturan O, Kuku I, Kaya E, Sevins A, Yildiz R. Bilateral transient hearing loss associated with vincristine therapy: case report. J Chemother 2000; 12 (6): 530–532.
- Schweitzer VG. Ototoxicity of chemotherapeutic agents. Otolaryngol Clin North Am 1993; 26 (5): 759–789.
- Yousif H, Richardson SG, Saunders WA. Partially reversible nerve deafness due to vincristine. Postgrad Med J 1990; 66 (778): 688–689.
- Mahajan SL, Ikeda Y, Myers TJ, Baldini MG. Acute acoustic nerve palsy associated with vincristine therapy. Cancer 1981; 47 (10) : 2404–2406.
- Lugassy G, Shapira A. A prospective cohort study of the effect of vincristine on audition. Anticancer Drugs 1996; 7 (5): 525–526.
- Moss PE, Hickman S, Harrison BR. Ototoxicity associat-ed with vinblastine. Ann Pharmacother 1999; 33 (4): 423–425.
- Serafy A, Hashash M. The effect of vincristine on the neurological elements of the rabbit cochlea. J Laryngol Otol 1981; 95 (1): 49–53.